This document discusses the history and growth of advertising and commercial culture. It notes how sports facilities and college football bowl games have increasingly taken on corporate sponsorship names. It provides statistics on the rise in advertising time for prime time TV between 1988 and 2007. The document also summarizes the history of advertising, from ancient Babylon to the development of modern ad agencies in the late 1800s. It discusses the influence of visual design trends and MTV on advertising and covers persuasive techniques used to influence consumers. Critical issues discussed include the influence of advertising on children and debates around health, tobacco, alcohol and prescription drug advertising.
McDonald's Nocturnivore PR Campaign Case StudyMegan Zart
For my Public Relations class at Ithaca College, we were tasked with analyzing a case study and presenting it to the class. Along with a group of two other students, I analyzed McDonald's Nocturnivore campaign, which promoted new extended hours during which breakfast was served.
A detailed analysis of Harvard Business School's case study of Procter and Gamble. Prepared by Kandukuri Sai Omkar a 3rd yr Undergraduate student at BITS Pilani K.K Birla Goa Campus during an marketing internship under Prof. Sameer Mathur.
McDonald's Nocturnivore PR Campaign Case StudyMegan Zart
For my Public Relations class at Ithaca College, we were tasked with analyzing a case study and presenting it to the class. Along with a group of two other students, I analyzed McDonald's Nocturnivore campaign, which promoted new extended hours during which breakfast was served.
A detailed analysis of Harvard Business School's case study of Procter and Gamble. Prepared by Kandukuri Sai Omkar a 3rd yr Undergraduate student at BITS Pilani K.K Birla Goa Campus during an marketing internship under Prof. Sameer Mathur.
My Keynote Presentation at Media 2010 (www.media2010.com.au), The Fall of AOR. I predicted we will continue to see the fall of the AOR model in advertising as consumers have now become "Co-Creators" of products and merely as influencers, or co-story tellers, Ad agencies are forced to embrace the demand of consumers and at the same time, brands/advertisers are under heavy pressure to see measurable results and ROI fast. Brands are not going to wait for AOR to integrate traditional and digital, but instead, agencies are forced to collaborate, and move away from this singular, AOR approach.
Eye Care Marketing From Buy One Get One Free to Marketing 5.0.pptxOptical Forum
Presentation Title
Eye Care Marketing: from “Buy One Get One” to Marketing 5.0
Overview
BOGOF or simply put BOGO which are the acronyms for “Buy One Get One Free”, is one of the world’s oldest promotional techniques. It is simple and popular however today’s businesses need to progressively gamify their promotions to stand out against mediocrity and thrive in the modern professional landscape. In this lecture we will discuss with participants marketing in eye care from Marketing 1.0 to Marketing 5.0 and show some of the ideas throughout history as well as the latest ideas that distinguish this field. In the fifty minutes’ session we will also highlight additional required and optional skills to master and succeed in building competitive advantage and sustainable growth using effective eye care marketing strategies.
Presenter
Dr. Gilbert Nacouzi
Biography
Dr. Gilbert Nacouzi
Is an Optometrist by trade and did research in Entrepreneurship.
After completing his Bachelor's Degree in Optometry he studied strategy at Harvard Business School, Boston, USA
An MBA, Master of Business Administration with a concentration in Healthcare Management at Marylhurst University at Portland, Oregon USA
A DBA, Doctorate of Business Administration, and research in Business Administration, at Columbia Southern University, Orange Beach Alabama, USA.
Doctor Nacouzi has more than two decades of experience in working in the retail industry and building healthcare and eye care business models. He is the owner of Optic Nacouzi and he serves as Editor in Chief at Optical Forum Flipbook Magazine.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
My Keynote Presentation at Media 2010 (www.media2010.com.au), The Fall of AOR. I predicted we will continue to see the fall of the AOR model in advertising as consumers have now become "Co-Creators" of products and merely as influencers, or co-story tellers, Ad agencies are forced to embrace the demand of consumers and at the same time, brands/advertisers are under heavy pressure to see measurable results and ROI fast. Brands are not going to wait for AOR to integrate traditional and digital, but instead, agencies are forced to collaborate, and move away from this singular, AOR approach.
Eye Care Marketing From Buy One Get One Free to Marketing 5.0.pptxOptical Forum
Presentation Title
Eye Care Marketing: from “Buy One Get One” to Marketing 5.0
Overview
BOGOF or simply put BOGO which are the acronyms for “Buy One Get One Free”, is one of the world’s oldest promotional techniques. It is simple and popular however today’s businesses need to progressively gamify their promotions to stand out against mediocrity and thrive in the modern professional landscape. In this lecture we will discuss with participants marketing in eye care from Marketing 1.0 to Marketing 5.0 and show some of the ideas throughout history as well as the latest ideas that distinguish this field. In the fifty minutes’ session we will also highlight additional required and optional skills to master and succeed in building competitive advantage and sustainable growth using effective eye care marketing strategies.
Presenter
Dr. Gilbert Nacouzi
Biography
Dr. Gilbert Nacouzi
Is an Optometrist by trade and did research in Entrepreneurship.
After completing his Bachelor's Degree in Optometry he studied strategy at Harvard Business School, Boston, USA
An MBA, Master of Business Administration with a concentration in Healthcare Management at Marylhurst University at Portland, Oregon USA
A DBA, Doctorate of Business Administration, and research in Business Administration, at Columbia Southern University, Orange Beach Alabama, USA.
Doctor Nacouzi has more than two decades of experience in working in the retail industry and building healthcare and eye care business models. He is the owner of Optic Nacouzi and he serves as Editor in Chief at Optical Forum Flipbook Magazine.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
5. Our increasingly sponsored
lives
• Sports facilities:
– Coors Field (Denver)
– United Center (Chicago)
– Fleet Center (Boston)
– Bank One Ballpark (Arizona)
– McLeod Arena
7. TV: 1 hour prime time TV
–1988: 10:17 ads
–1998: 15:40 ads
–2004: 16:27
–2005: 17:00
–2007:
8. Advertising History
• 3000 B.C. - ancient Babylon, shop
owners hung signs
• U.S: early 1800s -- first ad agencies
were space brokers. Bought
newspaper space and resold it.
• 1875: N.W. Ayer, first modern ad
agency, Philadelphia.
9. Advertising History
• Late 1800s -- department stores and
patent medicines as major advertisers.
• Advertising invented “problems” that
needed to be solved by products
– E.g., Odor Oh No
– AXE soap
10. • Radio: first ad, 1922
– Advertise to people in their living rooms
– Targeted kids
– Sell soap on soap operas
11. • Slogans
–No More Tears (Johnson & Johnson)
–Nobody Doesn’t Like Sara Lee (Sara Lee)
–Nothin' says lovin' like somethin' from the
oven (Pillsbury)
–Once you pop, you can't stop! (Pringles)
–M'm, M'm, Good! (Campbell's)
–Quality is Job 1. (Ford)
–Snap! Crackle! Pop! (Kellogg's Rice Krispies)
–See the USA in your Chevrolet. (Chevrolet)
13. Advertising Today
• Influence of visual design:
– 1960s-70s -- European design
– 1980s -- MTV -- changes visual style for TV
ads, makes hit music part of advertising
– 1990s --
14. Advertising Today
• Influence of visual design:
– 1960s-70s -- European design
– 1980s -- MTV -- changes visual style for TV
ads, makes hit music part of advertising
– 1990s -- the Internet
• Google
• Yahoo!
• MSN
17. Advertising Today
• The Structure of Agencies
– Market Research - VALS (SRI Business
Consulting)
– Creative Development
– Media Selection
– Account and Client Management
18. Persuasive Techniques
• Famous person testimonial
• Plain folks
• Snob appeal
• Bandwagon effect
• Hidden fear
• Irritation
• Unique selling proposition
19. Persuasive Techniques
• Association Principle -- associate
product with a positive cultural image or
value
• Disassociation Corrolary
• Liberation Marketing - product takes the
language of rebellion, nonconformity
20. Persuasive Techniques
• Myth Analysis
(Claude Levi-Strauss)
– Narrative -- tells us a story
– Binary Opposition - conflict
– Resolution
21. Critical Issues in Advertising
1) Children and advertising
– Influence $500 billion in spending each
year
– Advertising in Schools
• Channel One
22. Critical Issues in Advertising
2) Health and Advertising
– Eating Disorders
– Tobacco
– Alcohol
– Prescription Drugs
• Not advertised until 1997
• $4.7 billion in 2005
• FDA enforcement of misleading claims on the decline
23. Critical Issues in Advertising
Advertising and Democracy
Broadcasters earned from political ads:
1996 -$400 million
2000 -$665 million
2004 -$1.6 billion
2008: $2.5 billion
Campaign ads are about 10% of total
revenue in those years. How does this affect
broadcasters’ support for campaign finance
reform?
